-
Imprimis Challenges Mallinckrodt's Acthar
Tuesday, March 21, 2017 - 4:33pm | 462Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) wants to stop egregious drug pricing issues, and Mallinckrodt PLC (NYSE: MNK) is its next target. Imprimis announced it will pursue a lower priced alternative to Mallinckrodt's HP Acthar Gel, which grossed sales of $1.3 billion in the prior year....
-
Market Wrap For March 14: Ukraine Tension Drag Markets Lower
Friday, March 14, 2014 - 5:17pm | 2348U.S. stocks declined as concerns escalated over Ukraine, two days before its citizens will vote in a referendum to split from Ukraine and become part of Russia. Russian President Vladimir Putin is gearing up to “invade eastern Ukraine” as a six hour talk between U.S. Secretary of State John...